2-((3-(trifluoromethyl)phenyl)amino)naphthalene-1,4-dione | 3144-94-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 2-((3-(trifluoromethyl)phenyl)amino)naphthalene-1,4-dione
• 英文别名: 2-{[3-(Trifluoromethyl)phenyl]amino}naphthalene-1,4-dione；2-[3-(trifluoromethyl)anilino]naphthalene-1,4-dione
• CAS: 3144-94-3
• 化学式: C₁₇H₁₀F₃NO₂
• mdl: MFCD00396952
• 分子量: 317.267
• InChiKey: DSCHUUYMIDLFGF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  23
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  46.2
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-((3-(trifluoromethyl)phenyl)amino)naphthalene-1,4-dione 在 氧气 、 palladium diacetate 、 copper(II) acetate monohydrate 、 potassium carbonate 、 三甲基乙酸 作用下， 生成
  参考文献：
  名称：

  通过CH官能化合成新型取代的甲氧基苯并[2,3- b ]咔唑衍生物。其光物理性质的实验和理论表征

  摘要：

  通过苯胺与萘醌的氧化偶合，然后钯催化的氧化C H官能化和一锅还原甲基化反应，制备了新颖的高蓝色荧光N-甲基-6,11-二甲氧基苯并[2,3- b ]咔唑衍生物。对苯并咔唑荧光团进行了光物理表征，并研究了取代基的作用。（TD）-DFT计算忠实地再现了苯并咔唑的实验光物理性质，并揭示了取代基如何影响这些化合物的光物理性质。

  DOI：

  10.1016/j.dyepig.2016.08.012
• 作为产物：
  描述：

  间氨基三氟甲苯 、 1,4-萘醌 在 copper(II) acetate monohydrate 、 溶剂黄146 作用下， 反应 0.5h， 以90%的产率得到2-((3-(trifluoromethyl)phenyl)amino)naphthalene-1,4-dione
  参考文献：
  名称：

  催化量乙酸铜（II）存在下通过苯胺的氧化偶合反应实现1,4-萘醌的CH功能化

  摘要：

  发现苯胺（2）与1,4-萘醌（3）的氧化加成以产生N-芳基-2-氨基-1,4-萘醌（1）被乙酸铜（II）催化。在没有催化剂的情况下，反应变慢并且由于形成许多副产物而给出较低的收率。在10mol％的水合乙酸铜（II）的存在下，反应通常更有效，因为它们更清洁，产率更高并且更快。

  DOI：

  10.1021/jo200354u

文献信息

• Photoinduced EDA Complexes Enabled Radical Tandem Cyclization/Arylation of Unactivated Alkene with 2-Amino-1,4-naphthoquinones
  作者：Bin Sun、Xiayue Shi、Xiaohui Zhuang、Panyi Huang、Rongcheng Shi、Rui Zhu、Can Jin

  DOI：10.1021/acs.orglett.1c00268

  日期：2021.3.5

  A visible-light-induced radical tandem cyclization/arylation between 2-amino-1, 4-naphthoquinone and N-allyl-2-bromo-2,2-difluoroacetamides has been developed without an external photocatalyst. The transformation could be carried out at room temperature and gave a variety of C-3-functionalized 2-amino-1,4-naphthoquinone derivatives in moderate to excellent yields. Moreover, mechanistic studies revealed

  已经开发了在没有外部光催化剂的情况下在2-氨基-1、4-萘醌和N-烯丙基-2-溴-2,2-二氟乙酰胺之间的可见光诱导的自由基串联环化/芳基化。该转化可以在室温下进行，并以中等至优异的产率得到各种C-3-官能化的2-氨基-1,4-萘醌衍生物。此外，机理研究表明，反应是由电子供体-受体（EDA）配合物的形成驱动的。
• INHIBITORS OF THE MITF MOLECULAR PATHWAY
  申请人：THE GENERAL HOSPITAL CORPORATION

  公开号：US20160130222A1

  公开（公告）日：2016-05-12

  Provided herein are compounds of the formula (IV) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful as MITF inhibitors, MITF pathway inhibitors and for the treatment of cancer.

  本文提供的是公式（IV）的化合物及其药学上可接受的盐，其中取代基如规范中所披露的那样。这些化合物及其含有的药物组合物可用作MITF抑制剂、MITF通路抑制剂以及治疗癌症的药物。
• Discovery of Novel 2-Aniline-1,4-naphthoquinones as Potential New Drug Treatment for Leber’s Hereditary Optic Neuropathy (LHON)
  作者：Carmine Varricchio、Kathy Beirne、Pascale Aeschlimann、Charles Heard、Malgorzata Rozanowska、Marcela Votruba、Andrea Brancale

  DOI：10.1021/acs.jmedchem.0c00942

  日期：2020.11.25

  Leber's hereditary optic neuropathy (LHON) is a rare genetic mitochondrial disease and the primary cause of chronic visual impairment for at least 1 in 10 000 individuals in the U.K. Treatment options remain limited, with only a few drug candidates and therapeutic approaches, either approved or in development. Recently, idebenone has been investigated as drug therapy in the treatment of LHON, although evidence for the efficacy of idebenone is limited in the literature. NAD(P)H:quinone oxidoreductase 1 (NQO1) and mitochondrial complex III were identified as the major enzymes involved in idebenone activity. Based on this mode of action, computer-aided techniques and structure-activity relationship (SAR) optimization studies led to the discovery of a series naphthoquinone-related small molecules, with comparable adenosine 5'-triphosphate (ATP) rescue activity to idebenone. Among these, three compounds showed activity in the nanomolar range and one, 2-((4-fluoro-3-(trifluoromethyl)phenyl)amino)-3-(methylthio)naphthalene-1,3-dione (1), demonstrated significantly higher potency ex vivo, and significantly lower cytotoxicity, than idebenone.
• BIOMARKERS PREDICTIVE OF CANCER CELL RESPONSE TO ML329 OR A DERIVATIVE THEREOF
  申请人：Dana-Farber Cancer Institute, Inc.

  公开号：US20220128562A1

  公开（公告）日：2022-04-28

  The present invention is based in part on the identification of biomarkers, including NQO1, NRF2 and KEAP1, predictive of cancer cell responsiveness to treatment with ML 329 or a derivative thereof.
• US9745261B2
  申请人：——

  公开号：US9745261B2

  公开（公告）日：2017-08-29